Giant cell arteritis: early diagnosis is key

Giant cell arteritis (GCA) is an inflammatory vasculitis typically affecting elderly that can potentially cause vision loss. Studies have demonstrated that early recognition and initiation of treatment can improve visual prognosis in patients with GCA. This review addresses the benefits of early dia...

Descripción completa

Detalles Bibliográficos
Autores principales: Baig, Iyza F, Pascoe, Alexis R, Kini, Ashwini, Lee, Andrew G
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6340646/
https://www.ncbi.nlm.nih.gov/pubmed/30697092
http://dx.doi.org/10.2147/EB.S170388
_version_ 1783388821693399040
author Baig, Iyza F
Pascoe, Alexis R
Kini, Ashwini
Lee, Andrew G
author_facet Baig, Iyza F
Pascoe, Alexis R
Kini, Ashwini
Lee, Andrew G
author_sort Baig, Iyza F
collection PubMed
description Giant cell arteritis (GCA) is an inflammatory vasculitis typically affecting elderly that can potentially cause vision loss. Studies have demonstrated that early recognition and initiation of treatment can improve visual prognosis in patients with GCA. This review addresses the benefits of early diagnosis and treatment, and discusses the available treatment options to manage the disease.
format Online
Article
Text
id pubmed-6340646
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-63406462019-01-29 Giant cell arteritis: early diagnosis is key Baig, Iyza F Pascoe, Alexis R Kini, Ashwini Lee, Andrew G Eye Brain Review Giant cell arteritis (GCA) is an inflammatory vasculitis typically affecting elderly that can potentially cause vision loss. Studies have demonstrated that early recognition and initiation of treatment can improve visual prognosis in patients with GCA. This review addresses the benefits of early diagnosis and treatment, and discusses the available treatment options to manage the disease. Dove Medical Press 2019-01-17 /pmc/articles/PMC6340646/ /pubmed/30697092 http://dx.doi.org/10.2147/EB.S170388 Text en © 2019 Baig et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Review
Baig, Iyza F
Pascoe, Alexis R
Kini, Ashwini
Lee, Andrew G
Giant cell arteritis: early diagnosis is key
title Giant cell arteritis: early diagnosis is key
title_full Giant cell arteritis: early diagnosis is key
title_fullStr Giant cell arteritis: early diagnosis is key
title_full_unstemmed Giant cell arteritis: early diagnosis is key
title_short Giant cell arteritis: early diagnosis is key
title_sort giant cell arteritis: early diagnosis is key
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6340646/
https://www.ncbi.nlm.nih.gov/pubmed/30697092
http://dx.doi.org/10.2147/EB.S170388
work_keys_str_mv AT baigiyzaf giantcellarteritisearlydiagnosisiskey
AT pascoealexisr giantcellarteritisearlydiagnosisiskey
AT kiniashwini giantcellarteritisearlydiagnosisiskey
AT leeandrewg giantcellarteritisearlydiagnosisiskey

Ejemplares similares